ArticlePediatric blood & cancer2023

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.

Katherine Tarlock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.